27th Annual Lynn Sage Breast Cancer Symposium

Thursday, October 23, 2025, 9:00 AM - Sunday, October 26, 2025, 11:00 AM, Radisson Blu Aqua Hotel, Chicago, IL


This educational initiative was developed to bring together leading national and international medical, surgical, and radiation oncologists to present, debate, and evaluate cutting-edge technology and approaches in the management of breast cancer.

1. Evaluate the impact of obesity, menopause, and metabolic biomarkers on breast cancer risk and prognosis
2. Differentiate between common and rare breast tumor biomarkers and their clinical implications
3. Compare imaging strategies aimed at reducing breast cancer disparities and demonstrate knowledge of at least two novel imaging modalities
4. Explain the biological differences between lobular and ductal breast cancer
5. Discuss an evidence-based treatment strategy for patients with triple-negative breast cancer who do not achieve a pathological complete response (non-pCR) after neoadjuvant chemotherapy
6. Critically assess the role of cryoablation and preoperative radiation therapy in breast cancer management
7. Evaluate the evidence supporting the omission of surgery in certain breast cancer subgroups and apply multidisciplinary decision-making principles to treatment planning

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 22.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (22.50 hours), ABIM MOC Part 2 (22.50 hours), Non-Physician Attendance (22.50 hours)

Mitigation of Relevant Financial Relationships

Feinberg School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a Continuing Education activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.